Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,761 | -42,683 | -19,627 | 5,643 | -116,835 |
| Depreciation Amortization | 19,846 | 14,017 | 9,297 | 4,569 | 18,523 |
| Accounts receivable | 52,596 | 48,305 | 47,929 | -13,464 | 2,252 |
| Accounts payable and accrued liabilities | 2,055 | -899 | -664 | -5,885 | -6,305 |
| Other Working Capital | 53,665 | 48,403 | 52,116 | -8,891 | 48,858 |
| Other Operating Activity | -68,412 | -44,107 | -60,186 | -5,287 | 28,761 |
| Operating Cash Flow | $22,989 | $23,036 | $28,865 | $-23,315 | $-24,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -98,962 | -84,047 | -107,085 | -1,692 | -13,363 |
| PPE Investments | -2,583 | -2,033 | -1,256 | -218 | -1,073 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 79 |
| Purchase Of Investment | -2 | N/A | -102 | -105 | 489 |
| Sale Of Investment | N/A | -3 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,260 | -65 | -37 | -37 | N/A |
| Other Investing Activity | -1,261 | -64 | -37 | -36 | -1,642 |
| Investing Cash Flow | $-102,808 | $-86,147 | $-108,480 | $-2,051 | $-15,510 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,201 | 16,317 | 16,207 | 16,251 | 29,671 |
| Debt Repayment | -5,001 | -3,954 | -2,621 | -1,315 | -5,107 |
| Common Stock Issued | 82,822 | 82,823 | 82,823 | N/A | 67,936 |
| Other Financing Activity | -11,909 | -8,998 | -6,003 | -3,040 | -9,635 |
| Financing Cash Flow | $89,113 | $86,188 | $90,406 | $11,896 | $82,865 |
| Exchange Rate Effect | -2,752 | -697 | 1,542 | -267 | 884 |
| Beginning Cash Position | 136,708 | 136,708 | 136,708 | 136,708 | 93,216 |
| End Cash Position | 143,251 | 159,087 | 149,042 | 122,971 | 136,708 |
| Net Cash Flow | $6,543 | $22,379 | $12,334 | $-13,737 | $43,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,989 | 23,036 | 28,865 | -23,315 | -24,746 |
| Capital Expenditure | -2,583 | -2,033 | -1,256 | -218 | -1,073 |
| Free Cash Flow | 20,406 | 21,003 | 27,609 | -23,533 | -25,819 |